Memantine has been approved for use in moderate to severe Alzheimer’s Disease (AD) [27] and interest in its possible use in DS originally stemmed from functional information on one Hsa21 encoded protein, regulator of calcineurin 1, RCAN1. This evidence concerns the gene RCAN1 and Alzheimer disease.